The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes.
The capital expansion program commenced in June 2022 and is expected to complete in 2024
Under the agreement, Univar Solutions customers in Brazil and Mexico will have access to Ashland's binders and disintegrants for solid dosage forms, matrix formers for modulated release drugs and coatings for regular and modulated release solid dosage forms
The science leader comes with a rich experience in the employment testing industry
ekincare has raised a total funding of $22M since 2015 till date
The freshly infused capital will primarily be deployed towards expansion and research & development
The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service
30 beneficiaries avail of services per minute
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Subscribe To Our Newsletter & Stay Updated
